Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.

Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey

171 visualizaciones

Publicado el

Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' SurveyTwo patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on Metastatic Clear Cell Renal Cell Cancer for their open responses on clinical decisions. Patient progression reveals decisions in treatment throughout patient stages, factors influencing their decisions, barriers to optimal care, and confidence in treatment. Patients include:1) Elderly patient with good prognosis metastatic clear cell carcinoma2) Clear cell carcinoma and comorbiditiesData has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for the oncology prescribing data that you are missing - directly from high-prescribing US oncologists on Metastatic Clear Cell Renal Cell Cancer. Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with the introduction of new products that all have an impact oncologists' choices. This report is part of a series of oncology reports that allow you to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues in advanced stages of cancer. This report allows you to:' Understand what occurs with actual patients' Access the most up-to-date prescribing trends' Gain actionable data for developing and improving your market strategies' Pinpoint needs of your target audience' Focus resources to maximize the effectiveness of your budget' Understand where your product fits' Understand where your competitor's product fits' Design messages to advance brand performance

  • Inicia sesión para ver los comentarios

Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists' Survey

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from aUS Oncologists SurveyPublished on February 2011 Report SummaryMetastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists SurveyTwo patient specific case scenarios that unfold throughout the report, presented to 119 high-prescribing oncologists on MetastaticClear Cell Renal Cell Cancer for their open responses on clinical decisions. Patient progression reveals decisions in treatmentthroughout patient stages, factors influencing their decisions, barriers to optimal care, and confidence in treatment. Patients include:1) Elderly patient with good prognosis metastatic clear cell carcinoma2) Clear cell carcinoma and comorbiditiesData has been synthesized to show all responses and direct quotes from the oncologists. This is the primary research for theoncology prescribing data that you are missing - directly from high-prescribing US oncologists on Metastatic Clear Cell Renal CellCancer.Treatment decisions for advanced stages of renal cell cancer are difficult to track as information quickly changes along with theintroduction of new products that all have an impact oncologists choices. This report is part of a series of oncology reports that allowyou to see what is actually happening at the patient level for different types of patients presenting with a wide range of issues inadvanced stages of cancer.This report allows you to: Understand what occurs with actual patients Access the most up-to-date prescribing trends Gain actionable data for developing and improving your market strategies Pinpoint needs of your target audience Focus resources to maximize the effectiveness of your budget Understand where your product fits Understand where your competitors product fits Design messages to advance brand performance Table of ContentTable of ContentsExecutive Summary5Chapter 1: Introduction7Table 1. Treatment Options in Renal Cell Cancer7Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists Survey (From Slideshare) Page 1/4
  2. 2. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!Chapter 2. Survey Respondent Demographics9Table 2. Eligibility Criteria for Survey Participation9Figure 2.1 Gender of Survey Respondents9Figure 2.2 Years since Medical School Graduation10Figure 2.3 Practice Settings10Figure 2.4 Practices in NCI Cancer Centers11Figure 2.5 Geographic Settings11Figure 2.6 Survey Respondents by States Renal Cell Cancer Mortality12Figure 2.7 Number of Physicians in Practice Groups13Figure 2.8 Minimal Acceptable Level of Evidence in Determining Treatment Regimen13Chapter 3: Treatment of an Elderly Patient with Metastatic Clear Cell Renal Cell Carcinoma14Figure 3.1 Treatment Regimen Chosen Following Surgery14Figure 3.2 Adding Therapeutic Agents with Initial Treatment15Figure 3.3 Treatment Decision for Medication Toxicity16Figure 3.4 Second-Line Therapy17Figure 3.5 Factors Influencing Treatment18Figure 3.6 Confidence in Managing Clear Cell Renal Cell Carcinoma19Figure 3.8 Most Important Barrier to Optimal Patient Management21Chapter 4. Treatment of a Patient with Metastatic Clear Cell Renal Cell Carcinoma with Comorbidities23Figure 4.1 Management of Patient with Metastatic Disease and Comorbidities23Figure 4.2 Choice of Systemic Therapy Agent24Figure 4.3 Test to Monitor to Evaluate Increased Fatigue with Pazopanib25Figure 4.4 Next Systemic Treatment Choice for Progressive Disease26Chapter 5: Summary27Appendix A: Survey Instrument28Companies mentionedNovartis, Genentech/Roche, Onyx/Bayer, Pfizer, GlaxoSmithKline, AmgenMetastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists Survey (From Slideshare) Page 2/4
  3. 3. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists Survey Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 499.00 Quantity: _____ CD-ROM--USD 2 499.00 Quantity: _____ Hard Copy--USD 2 499.00 Quantity: _____ Corporate License--USD 4 800.00 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists Survey (From Slideshare) Page 3/4
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93Metastatic Clear Cell Renal Cell Carcinoma: Clinical Insights from a US Oncologists Survey (From Slideshare) Page 4/4

×